Abstract
Provided are vaccine compositions comprising a liposome, a bacterial polysaccharide antigen, and an invariant natural killer T (iNKT) cell agonist, methods of treating or preventing a bacterial infection using the compositions, and nasal spray devices comprising them.
| Original language | English |
|---|---|
| IPC | A61P 31/ 04 A I |
| Patent number | WO2025093613 |
| Filing date | 30/10/2024 |
| Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
| Priority date | 30/10/2023 |
| Priority number | EP20230206743 |
| Publication status | Published - 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Invariant natural killer t cell-activating vaccine against bacterial infections'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver